iiinova — where your digital self keeps evolving

Bojmar's lab @bojmarlab.bsky.social · 26/03/2026

🧫 🩺 Meet Ardita Medical student, currently conducting her thesis work at the Bojmar lab. Her project focuses on extracellular vesicles and hepatic IBA1 expression in relation to colon cancer progression.

100

Bojmar's lab @bojmarlab.bsky.social · 19/11/2025

Feeling incredibly grateful to @vetenskapsradet.bsky.social for supporting our research at @liu.se with grants for two of our exciting projects:

121

Bojmar's lab @bojmarlab.bsky.social · 18/11/2025

🧫 🩺 Meet Chuanwen Fan He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.

110

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🧫 🩺 Meet Håkon Andersen Blomstrand Pathologist, MD PhD Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🧬 Meet Carolin Jönsson Research Engineer Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.

110

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Bergthor Björnsson MD, PhD, Docent / Senior Consultant Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Per Sandström Adjungerad professor, MD/PhD Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🧬 Meet Mohamed Elhusseiny Post-doc Researcher His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🔬 Meet Alexander Sandberg PhD, Principal Research Engineer During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Paulina Velasco Riestra MD Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Constantinos Zambirinis MD, MRes Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Verena Unterkircher MD Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.

100

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🩺 Meet Erik Lundqvist MD, Surgical Consultant, PhD. A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.

120

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🩺️ Meet Karin Johansen MD, PhD From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.

110

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🔬 Meet Jonas Burman PhD candidate Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.

100

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🩺 Meet Elena Arlaman MD, PhD candidate Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.

100

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🧪 Meet Linda Bojmar PhD, Assistant Professor, Docent Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.

100

Reposted by Bojmar's lab

Linköping University @liu.se · 04/09/2025

Cancer researcher Linda Bojmar at Linköping University has been awarded a Starting Grant from @erc.europa.eu to study how pancreatic #cancer spreads — and how treatment can be tailored to each patient. #AcademicSky 🧪 liu.se/en/news-item/erc-starting-grant-till-linda-bojmar

liu.se

ERC Starting Grant to Linda Bojmar

Linda Bojmar has been awarded just over SEK 16 million from the European Research Council, ERC. Her research aims to increase understanding of how pancreatic cancer spreads in the body and how treatme...

072

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

Yesterday the @erc.europa.eu announced the 2025 Starting Grant winners. We’re beyond thrilled and grateful that our project SYST-E-MET: Systemic Effects on Metastasis – a look beyond the tumor was selected for funding!

120

Reposted by Bojmar's lab

Let's Win Pancreatic Cancer @letswinpc.org · 23/06/2025

The 2025 ASCO meeting featured research on pancreatic cancer, including a new treatment modality and a novel treatment combination. bit.ly/43VHWOL #OncoSky

bit.ly

Pancreatic Cancer Research Highlights from ASCO Annual Meeting

The 2025 ASCO meeting featured pancreatic cancer research including a new treatment modality and a new treatment combination.

021

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

This work is the result of a great international collaboration! Huge thanks to Darrell Green and Emma Bull for bringing together such a strong multidisciplinary team. Check out our review on paediatric bone sarcomas #PaedsOnc #SarcomaResearch molecular-cancer.biomedcentral.com/articles/10....

molecular-cancer.biomedcentral.com

Targeting metastasis in paediatric bone sarcomas - Molecular Cancer

Paediatric bone sarcomas (e.g. Ewing sarcoma, osteosarcoma) comprise significant biological and clinical heterogeneity. This extreme heterogeneity affects response to systemic therapy, facilitates inh...

031

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

We are a part of the #FOSTER consortium (Fight OsteoSarcoma Through European Research). It proposes to connect multidisciplinary and patient/parent advocate expertise, at a Pan-European level to improve biological, translational and clinical research on #osteosarcoma to ultimately improve survival.

010

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

This year was the 7th Swedish Cancer Research Meeting #SCRM and for the first time @liu.se @liucancer.bsky.social took part in the national programme committee. A big thanks to Lund University Cancer Centre @lunduniversity.bsky.social for hosting this year’s gathering! This is our lab's insight:

131

Reposted by Bojmar's lab

Metastasis Research Society @metastasisresearch.bsky.social · 31/12/2024

6/Timing of pancreas cancer metastasis. By profiling patient samples, the authors reveal immune remodeling in the pre-metastatic liver and propose liver sampling to determine pancreas cancer metastatic propensity. David Lyden Weill Cornell www.nature.com/articles/s41...

nature.com

Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer - Nature Medicine

A multi-modal analysis of pre-metastatic liver biopsies from patients with localized pancreatic cancer with a minimum of 3 years of follow-up shows that immunological, proliferative and metabolomic fe...

162

Bojmar's lab @bojmarlab.bsky.social · 18/06/2025

Recently, we got to celebrate our postdoc Mohamed Elhusseiny. 2025 grant awardee from Dr Per Håkansson’s Foundation for Research! With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency. Did you know that cancer cells are addicted to methionine? 👀

100

Bojmar's lab @bojmarlab.bsky.social · 18/06/2025

We’re proud to be part of SSPAC (The Swedish Study group for Pancreatic Cancer). This spring we got to share our ongoing work on the Pre-Metastatic Liver study. #pancreaticcancer #SSPAC Our team didn’t just bring science, we also had milestones to celebrate! 🥳

100

Bojmar's lab @bojmarlab.bsky.social · 17/06/2025

A liver biopsy may predict spread of pancreatic cancer. This discovery holds the potential to improve how we anticipate disease progression and prevent pancreatic cancer from spreading to other organs.

The image illustrates the four prognostic liver lobes in the pre-metastatic liver: liver metastasis within 6 months (orange outline), liver metastasis after 6 months (red outline), metastases outside of liver (green outline), and normal liver with fatty liver and no evidence of cancer (light blue outline). Photo credit: Vanessa Dudley

100

Bojmar's lab @bojmarlab.bsky.social · 17/06/2025

We had the opportunity to take part in the very first Swedish Extracellular Vesicles Network meeting in Stockholm! 🧬 We presented our latest findings on cancer EVs as mediators of systemic disease. We got to say hejhej to our friend and colleague, David Lyden, who came all the way from New York!

110

Bojmar's lab @bojmarlab.bsky.social · 17/06/2025

Time to catch up on everything the lab’s been up to these past few weeks...and trust us, it’s been BUSY! 🧪💥 From late-night flow cytometry sessions to exciting conferences and new data from our EV studies, here’s a little peek behind the scenes… 👀👇 #LabLife #ScienceInProgress #CancerResearch

000

Bojmar's lab @bojmarlab.bsky.social · 18/03/2025

Welcome to our lab! We dive deep into the mysteries of GI cancers and their metastatic journey, unraveling patterns to outsmart cancer. Our mission? To turn cutting-edge research into real clinical impact. Follow along for discoveries, insights, and a shared passion for science! 🧬🔬 #CancerResearch

012